Company attributes
Industry
B2X
CEO
Founder
Legal Name
Cardiol Therapeutics Inc.
Legal classification
Date Incorporated
January 19, 2027
0Number of Employees (Ranges)
11 – 50
Email Address
info@cardiolrx.com0
Phone Number
+128991008500
Full Address
602-2265 Upper Middle Road East Oakville, ON L6H 0G50
CIK Number
Place of Incorporation
Founded Date
January 1, 2017
Total Funding Amount (USD)
26,396,327
Latest Funding Round Date
May 2020
Stock Symbol
CRDL
Exchange
CFO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
SIC Code
2,8360
Cardiol Therapeutics Inc. is a biotechnology company that develops therapies for inflammatory heart disease. It has commenced findings on its product, a oral cannabidiol formulation, in COVID-19 patients that have a history of cardiovascular disease.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
